Education
About Us
Working with TipRanks
Follow Us
Extrawell Pharmaceutical Holdings Limited (HK:0858)
:0858
RESEARCH TOOLSreports
0858 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.03 - HK$0.15
Previous CloseN/A
Volume550.00K
Average Volume (3M)19.12M
Market Cap
HK$298.75M
Enterprise Value-HK$725.99M
Total Cash (Recent Filing)HK$870.44M
Total Debt (Recent Filing)HK$130.18M
Price to Earnings (P/E)1.4
Beta0.76
Next Earnings
Nov 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.05
Shares Outstanding2,390,000,200
10 Day Avg. Volume13,135,000
30 Day Avg. Volume19,122,000
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Extrawell Pharmaceutical Holdings Limited News
0858 FAQ
What was Extrawell Pharmaceutical Holdings Limited’s price range in the past 12 months?
Extrawell Pharmaceutical Holdings Limited lowest stock price was HK$0.03 and its highest was HK$0.15 in the past 12 months.
What is Extrawell Pharmaceutical Holdings Limited’s market cap?
Extrawell Pharmaceutical Holdings Limited’s market cap is HK$298.75M.
When is Extrawell Pharmaceutical Holdings Limited’s upcoming earnings report date?
Extrawell Pharmaceutical Holdings Limited’s upcoming earnings report date is Nov 28, 2025 which is in 97 days.
How were Extrawell Pharmaceutical Holdings Limited’s earnings last quarter?
Extrawell Pharmaceutical Holdings Limited released its earnings results on Jun 30, 2025. The company reported HK$0.051 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.051.
Is Extrawell Pharmaceutical Holdings Limited overvalued?
According to Wall Street analysts Extrawell Pharmaceutical Holdings Limited’s price is currently Overvalued.
Does Extrawell Pharmaceutical Holdings Limited pay dividends?
Extrawell Pharmaceutical Holdings Limited does not currently pay dividends.
What is Extrawell Pharmaceutical Holdings Limited’s EPS estimate?
Extrawell Pharmaceutical Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Extrawell Pharmaceutical Holdings Limited have?
Extrawell Pharmaceutical Holdings Limited has 2,390,000,200 shares outstanding.
What happened to Extrawell Pharmaceutical Holdings Limited’s price movement after its last earnings report?
Extrawell Pharmaceutical Holdings Limited reported an EPS of HK$0.051 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Extrawell Pharmaceutical Holdings Limited?
Currently, no hedge funds are holding shares in HK:0858
Extrawell Pharmaceutical Holdings Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
250.00%
12-Months-Change
Fundamentals
Return on Equity
23.02%
Trailing 12-Months
Asset Growth
18.58%
Trailing 12-Months
Company Description
Extrawell Pharmaceutical Holdings Limited
Extrawell Pharmaceutical Holdings Limited (0858) is a biotechnology company based in Hong Kong, primarily engaged in the development, manufacturing, and distribution of pharmaceutical products. The company operates in the sectors of prescription drugs, over-the-counter medications, and health supplements. Extrawell focuses on innovative drug delivery systems and generic pharmaceuticals, catering to both local and international markets with a robust portfolio of healthcare solutions.
Technical Analysis
Huakang Biomedical Holdings Company Limited
―
Fusen Pharmaceutical Co., Ltd.
―
PuraPharm Corp. Ltd.
―
Kontafarma China Holdings Ltd
―
Qianhai Health Holdings Ltd.
―